Ewopharma is pleased to announce that it has entered into a strategic collaboration with Purpose Pharma for the commerci…
Ewopharma AG and Protina Pharmazeutische GmbH announce their new distribution partnership for Bulgaria. Ewopharma takes…
BioGaia AB (NASDAQ: BIOG) and Ewopharma AG have renewed their long-standing distribution partnership, reinforcing the co…
Ewopharma AG and Dr. Falk Pharma GmbH are extending their distribution partnership of more than 27 years – for many more…
Ewopharma is pleased to report that sugemalimab, licensed from partner CStone Pharmaceuticals, has received a I, A recom…
Ewopharma is pleased to report an important new regulatory milestone for sugemalimab licensed from Chinese partner CSton…
Effective June 1, 2024, Ewopharma AG has the exclusive licence to distribute Translumina’s drug-eluting stents (DES) and…
Ewopharma AG, a privately held Swiss healthcare group with subsidiaries in Central and Eastern Europe, is pleased to ann…
Ewopharma announces today that it has entered into a strategic commercial collaboration with CStone Pharmaceuticals (“CS…
Ewopharma AG, a privately held Swiss healthcare group with subsidiaries in Central and Eastern Europe, is pleased to ann…
